PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Income Growth
131.50%
TTM · Period ending:
PHAS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported131.50%period ending
Latest reported131.50%period ending
PHAS TTM Operating Income YoY % (-160.57% → 131.50%)
Year-over-year change
High-resolution chart · PNG
PHAS operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 131.5033% | |
| 125.8251% | |
| 112.0128% | |
| -44.3228% | |
| -52.0994% | |
| -106.2929% | |
| -113.5494% | |
| -94.2574% | |
| -107.4716% | |
| -93.1263% | |
| -102.2806% | |
| -150.1974% | |
| -160.5684% |